Antigens, antibodies, and membranous nephropathy: a decade of progress.

[1]  M. Jadoul,et al.  Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. , 2020, Kidney international.

[2]  U. Specks,et al.  Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. , 2019, Journal of the American Society of Nephrology : JASN.

[3]  A. Köttgen,et al.  Genetics of membranous nephropathy , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  A. Bomback,et al.  Membranous Nephropathy: Approaches to Treatment , 2018, American Journal of Nephrology.

[5]  L. Beck.  PLA2R and THSD7A: Disparate Paths to the Same Disease? , 2017, Journal of the American Society of Nephrology : JASN.

[6]  K. Nath,et al.  A Proposal for a Serology-Based Approach to Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[7]  D. Salant,et al.  Membranous Nephropathy: A Journey From Bench to Bedside. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  J. Klein,et al.  Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.

[9]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.